Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a gentle laser beam save your sight? new trial for AMD patients

NCT ID NCT07554690

First seen Apr 28, 2026 · Last updated Apr 30, 2026 · Updated 1 time

Summary

This study tests a non-invasive laser treatment called photobiomodulation in 67 people with early age-related macular degeneration (AMD) who have a specific type of deposit in their retina. The treatment uses low-energy light to stimulate cells and reduce inflammation. Participants will be randomly assigned to receive either the real laser or a fake treatment, and researchers will track changes in vision and eye structure over 12 months to see if the laser can slow disease progression.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMD - AGE-RELATED MACULAR DEGENERATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • IRCCS Fondazione G.B.Bietti c/o Ospedale Britannico

    Roma, Italy, 00184, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.